Published online May 21, 2026. doi: 10.3748/wjg.v32.i19.116837
Revised: January 23, 2026
Accepted: February 27, 2026
Published online: May 21, 2026
Processing time: 178 Days and 6.1 Hours
Liver transplantation (LT) is traditionally contraindicated in patients with active extrahepatic metastases due to concerns regarding futility, donor risk, organ al
To report two rescue LT cases undertaken for end-stage hepatic failure despite persistent extrahepatic metastases, and to construct an ethical-clinical decision framework applicable to similar exceptional scenarios.
We conducted a retrospective review of two patients who underwent rescue LT for hepatic failure with extrahepatic metastases. Clinical course, decision-making processes, donor consent procedures, and post-transplant outcomes were exa
One patient received a living donor graft after undergoing an enhanced informed-consent process that emphasized voluntariness, proportionality of risk, and understanding of the non-curative intent. The other patient received a deceased-donor graft, which proceeded after institutional review and confirmation that transplantation represented the only life-saving option. Postoperatively, both patients recovered normal liver function and were discharged with improved quality of life. The hepatoblastoma patient survived for 17 months post-LT, and the breast cancer patient for 9 months, with stable graft function but progressive extrahepatic disease. Both families expressed deep gratitude and satisfaction with the decision to pursue LT.
Although survival was limited, rescue LT allowed meaningful additional life in selected patients and was consistent with ethically defensible decision-making grounded in autonomy, beneficence, and compassion. However, such interventions must remain exceptional and require rigorous donor safeguards and transparent deliberation. Our proposed decision framework may support clinicians facing similar extreme scenarios and inform future discussions on exceptional indications for LT.
Core Tip: Rescue liver transplantation (LT) is generally considered futile in patients with extrahepatic metastases, yet in rare situations acute liver failure not tumor progression poses the true immediate threat to life. This study describes two such exceptional cases and proposes a structured ethical-clinical decision framework integrating futility assessment, donor safety, allocation fairness, and values-aligned consent. Our model outlines when rescue LT may be ethically and clinically de